Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease.
Gurumurthy P, Ramachandran G, Hemanth Kumar AK, Rajasekaran S, Padmapriyadarsini C, Swaminathan S, Bhagavathy S, Venkatesan P, Sekar L, Mahilmaran A, Ravichandran N, Paramesh P. Gurumurthy P, et al. Among authors: sekar l. Antimicrob Agents Chemother. 2004 Nov;48(11):4473-5. doi: 10.1128/AAC.48.11.4473-4475.2004. Antimicrob Agents Chemother. 2004. PMID: 15504887 Free PMC article. Clinical Trial.
Evaluation of a diagnostic algorithm for sputum smear-negative pulmonary tuberculosis in HIV-infected adults.
Padmapriyadarsini C, Tripathy S, Sekar L, Bhavani PK, Gaikwad N, Annadurai S, Narendran G, Selvakumar N, Risbud AR, Sheta D, Rajasekaran S, Thomas A, Wares F, Swaminathan S. Padmapriyadarsini C, et al. Among authors: sekar l. J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):331-8. doi: 10.1097/QAI.0b013e31829341af. J Acquir Immune Defic Syndr. 2013. PMID: 23599010
Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction.
Narendran G, Andrade BB, Porter BO, Chandrasekhar C, Venkatesan P, Menon PA, Subramanian S, Anbalagan S, Bhavani KP, Sekar S, Padmapriyadarshini C, Kumar S, Ravichandran N, Raja K, Bhanu K, Mahilmaran A, Sekar L, Sher A, Sereti I, Swaminathan S. Narendran G, et al. Among authors: sekar l, sekar s. PLoS One. 2013 May 17;8(5):e63541. doi: 10.1371/journal.pone.0063541. Print 2013. PLoS One. 2013. PMID: 23691062 Free PMC article. Clinical Trial.
Acquired rifampicin resistance in thrice-weekly antituberculosis therapy: impact of HIV and antiretroviral therapy.
Narendran G, Menon PA, Venkatesan P, Vijay K, Padmapriyadarsini C, Ramesh Kumar S, Bhavani KP, Sekar L, Gomathi SN, Chandrasekhar C, Kumar S, Sridhar R, Swaminathan S. Narendran G, et al. Among authors: sekar l. Clin Infect Dis. 2014 Dec 15;59(12):1798-804. doi: 10.1093/cid/ciu674. Epub 2014 Aug 25. Clin Infect Dis. 2014. PMID: 25156114 Clinical Trial.
Pharmacokinetics of first-line antituberculosis drugs in HIV-infected children with tuberculosis treated with intermittent regimens in India.
Ramachandran G, Kumar AK, Bhavani PK, Kannan T, Kumar SR, Gangadevi NP, Banurekha VV, Sekar L, Ravichandran N, Mathevan G, Sanjeeva GN, Dayal R, Swaminathan S. Ramachandran G, et al. Among authors: sekar l. Antimicrob Agents Chemother. 2015 Feb;59(2):1162-7. doi: 10.1128/AAC.04338-14. Epub 2014 Dec 8. Antimicrob Agents Chemother. 2015. PMID: 25487804 Free PMC article. Clinical Trial.
Effectiveness of symptom screening and incidence of tuberculosis among adults and children living with HIV infection in India.
Padmapriyadarsini C, Bhavani PK, Sekar L; Anandhachitra; Selvaraj M, Poornagangadevi N, Mothi SN, Nandagopal K, Vennila S, Priyadarshini GK, Manisha M, Sanjeeva G, Agarwal U, Suresh E, Rewari BB, Swaminathan S. Padmapriyadarsini C, et al. Among authors: sekar l. Natl Med J India. 2016 Nov-Dec;29(6):321-325. Natl Med J India. 2016. PMID: 28327478 Free article.
21 results